Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...

Inc. today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS). "We are pleased to see Abecma expansion in the third ...

Hypoxia, a condition characterized by reduced oxygen availability, has been widely studied for its potential therapeutic ...

Advise patients to report signs and symptoms of hypoxia immediately to a healthcare provider ... With one of the largest clinical development programs across more than 30 tumor types, we strive to ...

Here's what to know about flu symptoms in 2025, how to tell if it's something else, and how to protect yourself: But there are some differences. COVID-19 can show up later than the cold or flu ...

and have an oral presentation update on the hematotoxicity model and poster presentation on the impact of deep molecular remissions on clinical outcomes, which were both announced in December.” ...